UPDATED Sep 01, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
EXEL | US$37.42 | -2.4% | 44.9% | US$10.1b | US$44.74 | PE16.7x | E19.9% | n/a | ||
APN | R104.57 | 2.5% | -56.0% | R46.5b | R123.60 | PE10.4x | E19.8% | 3.4% | ||
NMRA | US$1.73 | -0.6% | -83.9% | US$280.2m | US$6.05 | PB1.5x | E19.8% | n/a | ||
500420 | ₹3,581.55 | -2.4% | 4.4% | ₹1.2t | ₹3,929.42 | PE60.5x | E19.7% | 0.9% | ||
BNTX | US$100.00 | -4.6% | 13.6% | US$24.0b | US$137.47 | PS7.1x | E19.7% | n/a | ||
OCS | US$16.13 | -8.0% | 34.4% | US$844.2m | US$37.42 | PS885.4x | E19.5% | n/a | ||
SEER | US$2.05 | -1.4% | 22.8% | US$120.5m | n/a | PS7.4x | E19.5% | n/a | ||
DNA | US$12.67 | -0.9% | 107.7% | US$702.2m | US$11.33 | PS3x | E19.5% | n/a | ||
688222 | CN¥25.32 | 10.2% | 187.7% | CN¥10.8b | CN¥27.20 | PE153.9x | E19.5% | 0.2% | ||
A195940 | ₩46,850.00 | -4.2% | -2.4% | ₩1.3t | ₩62,363.64 | n/a | E19.4% | 0.7% | ||
IBNSINA | ৳325.60 | 5.2% | 3.7% | ৳10.2b | ৳375.00 | PE16.1x | E19.4% | 1.9% | ||
300401 | CN¥14.53 | -8.7% | 16.1% | CN¥8.1b | CN¥15.00 | PE24x | E19.3% | 0.8% | ||
AUPH | US$11.99 | -1.8% | 79.5% | US$1.6b | US$11.71 | PE26x | E19.2% | n/a | ||
STVN | US$23.01 | 6.3% | 4.9% | US$6.3b | US$28.63 | PE39.9x | E19.2% | 0.3% | ||
PRQR | US$2.25 | 2.3% | 17.2% | US$237.0m | US$8.88 | PS11.8x | E19.1% | n/a | ||
AKRO | US$46.73 | -2.9% | 79.8% | US$3.7b | US$76.27 | PB3.6x | E19.1% | n/a | ||
688687 | CN¥33.12 | -8.2% | 69.8% | CN¥5.7b | CN¥47.33 | PE37.6x | E19.1% | 0.9% | ||
OBD | UK£0.0047 | 0% | -91.7% | UK£9.3m | n/a | PS10.4x | E19.0% | n/a | ||
BTAI | US$4.05 | -22.7% | -59.2% | US$59.0m | US$19.40 | PS67.9x | E19.0% | n/a | ||
2422 | CN¥39.94 | 4.6% | 29.1% | CN¥63.8b | CN¥41.78 | PE29.7x | E19.0% | 2.5% | ||
ENGN | US$4.62 | 6.0% | -31.3% | US$236.1m | US$21.40 | PB1x | E18.9% | n/a | ||
300406 | CN¥14.35 | -3.7% | 14.7% | CN¥8.4b | n/a | PE18.2x | E18.8% | 2.8% | ||
600085 | CN¥35.74 | -4.0% | 2.3% | CN¥49.5b | CN¥43.75 | PE33.8x | E18.8% | 1.4% | ||
688578 | CN¥115.29 | 21.2% | 144.5% | CN¥52.6b | CN¥99.04 | PE33.8x | E18.7% | 0.7% |